Independent Portfolio Consultants’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$141K Sell
4,808
-1,992
-29% -$54.4K 0.06% 355
2017
Q1
$173K Sell
6,800
-100
-1% -$2.58K 0.06% 354
2016
Q4
$177K Sell
6,900
-20
-0.3% -$525 0.06% 343
2016
Q3
$189K Sell
6,920
-920
-12% -$25.3K 0.06% 332
2016
Q2
$221K Buy
7,840
+660
+9% +$17K 0.07% 311
2016
Q1
$170K Buy
7,180
+1,940
+37% +$42.7K 0.05% 377
2015
Q4
$118K Buy
5,240
+1,080
+26% +$24.6K 0.04% 435
2015
Q3
$96K Sell
4,160
-240
-5% -$6.02K 0.02% 466
2015
Q2
$108K Buy
4,400
+1,080
+33% +$27K 0.02% 491
2015
Q1
$83K Buy
3,320
+20
+0.6% +$475 0.02% 514
2014
Q4
$76K Buy
3,300
+1,220
+59% +$27.9K 0.02% 567
2014
Q3
$49K Buy
+2,080
New +$48.8K 0.01% 632

Other funds holding TECH

Independent Portfolio Consultants's TECH Position: Q2 2017 in Review

Independent Portfolio Consultants reduced its Bio-Techne (TECH) stake by 29% in Q2 2017, selling an estimated $54.4K and leaving 4,808 shares worth $141K. The position accounts for 0.06% of the portfolio, ranked #355.

Independent Portfolio Consultants first reported a position in TECH in Q3 2014 and has held it in 12 quarters since. The position peaked at $221K in Q2 2016. 280 funds tracked by Wall St. Rank hold TECH as of Q2 2017.

  • Independent Portfolio Consultants held 4,808 shares of Bio-Techne worth $141K as of Q2 2017.
  • Independent Portfolio Consultants sold 1,992 Bio-Techne shares in Q2 2017, an estimated $54.4K.
  • Bio-Techne made up 0.06% of Independent Portfolio Consultants's portfolio in Q2 2017, its #355 holding.
  • Independent Portfolio Consultants first reported a position in Bio-Techne in Q3 2014 and has held it in 12 quarters since.
  • Independent Portfolio Consultants's Bio-Techne position peaked at $221K in Q2 2016.
  • 280 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2017.

Based on Independent Portfolio Consultants's 13F filing for Q2 2017, filed 6 Jul 2017.